top of page
The Female Heart: Differences in Cardiovascular Disease
The Minerva Project • December 19, 2025
Cardiovascular disease affects over 60 million women in the United States and remains the leading cause of death among them, often presenting with greater risks, complications, and diagnostic challenges than in men. Despite this prevalence, women’s cardiovascular disease has historically been understudied, contributing to disparities in disease treatment.
A large factor is sex differences, from physiological to genomic. For example, women have fewer cholesterol crystals and calcium deposits in their artery plaque than men, which contributes to the way cardiovascular disease presents. Women are also more likely to have cardiovascular issues presenting as multiple narrowed vessels, while men are more likely to have “clogged” arteries in a concentrated area that can be more easily treated via stent or bypass surgery. The X-chromosome plays an additional role, where several genes escaping the inactivation of one of the chromosomes in women are responsible for regulating processes like aortic valve stenosis, restricting blood flow to the heart.
Gender biases in healthcare further contribute to differences in disease outcomes. One study has shown that clinicians order less aggressive tests for female patients with borderline symptoms of cardiovascular disease than male. Despite this, more recent implementation of standards like sex-specific cutoffs for blood tests represent a step towards reducing gender gaps in cardiovascular care.
This underscores the critical need for more inclusive cardiovascular research, as many existing diagnostic criteria, treatment guidelines, and procedural standards are still derived from male data sets. Reducing inequity gaps requires systematically incorporating female-specific biological and clinical data.

bottom of page
